Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Death unexplained; This is a spontaneous report from a contactable physician downloaded from a regulatory authority FR-AFSSAPS-LY20212870 and received via a regulatory authority. A 90-year-old female patient received first dose of bnt162b2 (COMIRNATY, Lot: ET7205) intramuscular in left arm on 01Apr2021 at single dose for COVID-19 immunisation. Medical history included mixed dementia, partial epilepsy, CVA (cerebrovascular accident) and AVC (stroke) from 2000, 2005 and not ongoing, ACFA (AFib ,complete arrhythmia by atrial fibrillation) old, stopping anticoagulants since 2017, deglutition disorder (swallowing disorder with multiple pneumonia), osteoporosis, anaemia, cerebral amyloid angiopathy, antritis under PPI (proton pump inhibitors). No covid history. Concomitant medications included levetiracetam (KEPPRA), PPI proton pump inhibitors (unspecified). On 03Apr2021, in the evening, the patient took her meal in the chair and then went back to bed. 10min later, death was declared. She had no significant acute pathology, and had not presented any signs of vomiting, nor painful facies. The patient experienced unexplained death, the declarant mentions the multiple chronic pathologies that can lead to death, a possible massive stroke, and questions the role of the vaccine. The patient died on 03Apr2021. It was unknown if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Death unexplained
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166